Altobelli E, Blasetti A, Petrocelli R, Tumini S, Azzarone R, Tiberti S, Battistoni C, Merante D, Verrotti A, Fioroni M A, Iannarelli R, Poccia G, Papola F
Chair of Epidemiology, Department of Internal Medicine and Public Health, University of L'Aquila, Via Vetoio, Coppito Blocco 11B, I-67100 L'Aquila, Italy.
Clin Exp Med. 2005 Jul;5(2):72-9. doi: 10.1007/s10238-005-0069-0.
The objective was to evaluate HLA DR/DQ alleles and their risk factor for type 1 diabetes in the Abruzzo region (central Italy). Sixty incident cases from the Abruzzo region were studied together with 120 unrelated control subjects living in the same administrative areas. The relative risk of diabetes associated with the alleles under study was calculated by deriving the odds ratio (OR) maximum likelihood estimates and their 95% confidence intervals (CI) by the exponentiation of the logistic regression beta-parameter. The combination DRB103/DQA10501/DQB10201 was found in 20.0% of patients and 7.1% of the control subjects, conferring an OR of 4.04 and a CI of 1.97-8.49. The combination DRB104/DQA10301/DQB10302 was found in 23.3% of diabetic patients and 6.7% of controls, giving an OR of 5.69 and a CI of 2.77-12.05. DRB111/DQA10505/DQB10301 and DQA10505/DQB10301 were negatively associated with type 1 diabetes (OR=0.27, CI 0.11-0.57; OR=0.07, CI 0.02-0.19). The DQA1 genotype at risk was found to be DQA10301/DQA10501: OR=23.80, CI 2.97-190.89, as it occurred with the highest frequency in the patient group. The DQB1 genotype at risk was found to be DQB10201/DQB1*0302, which occurred in 13.3% of patients but in only 1.1% of the control group (OR=29.75, CI 5.36-549.25). Our results shed further light on the risk of development of this disease during a specific time period in an area where the overall incidence of type 1 diabetes is known.
目的是评估意大利中部阿布鲁佐地区1型糖尿病的HLA DR/DQ等位基因及其危险因素。对来自阿布鲁佐地区的60例新发病例与居住在相同行政区的120名无关对照者进行了研究。通过对逻辑回归β参数求幂得出比值比(OR)的最大似然估计值及其95%置信区间(CI),计算与所研究等位基因相关的糖尿病相对风险。在20.0%的患者和7.1%的对照者中发现了DRB103/DQA10501/DQB10201组合,其OR为4.04,CI为1.97 - 8.49。在23.3%的糖尿病患者和6.7%的对照者中发现了DRB104/DQA10301/DQB10302组合,OR为5.69,CI为2.77 - 12.05。DRB111/DQA10505/DQB10301和DQA10505/DQB10301与1型糖尿病呈负相关(OR = 0.27,CI 0.11 - 0.57;OR = 0.07,CI 0.02 - 0.19)。发现有风险的DQA1基因型为DQA10301/DQA10501:OR = 23.80,CI 2.97 - 190.89,因为它在患者组中出现的频率最高。发现有风险的DQB1基因型为DQB10201/DQB1*0302,在13.3%的患者中出现,但在对照组中仅为1.1%(OR = 29.75,CI 5.36 - 549.25)。我们的研究结果进一步揭示了在一个已知1型糖尿病总体发病率的地区,特定时间段内该疾病发生的风险。